Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Interest Coverage Ratio: 2022-2025

Historic Interest Coverage Ratio for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to -0.95.

  • Phathom Pharmaceuticals' Interest Coverage Ratio rose 75.25% to -0.95 in Q3 2025 from the same period last year, while for Sep 2025 it was -3.04, marking a year-over-year increase of 29.91%. This contributed to the annual value of -3.85 for FY2024, which is 3.35% up from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Interest Coverage Ratio of -0.95 as of Q3 2025, which was up 72.29% from -3.42 recorded in Q2 2025.
  • Phathom Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at -0.95 during Q3 2025, with a 5-year trough of -13.74 in Q1 2022.
  • In the last 3 years, Phathom Pharmaceuticals' Interest Coverage Ratio had a median value of -3.53 in 2023 and averaged -3.60.
  • In the last 5 years, Phathom Pharmaceuticals' Interest Coverage Ratio spiked by 76.25% in 2023 and then slumped by 31.98% in 2024.
  • Over the past 4 years, Phathom Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at -4.86 in 2022, then fell by 10.41% to -5.36 in 2023, then surged by 40.41% to -3.20 in 2024, then surged by 75.25% to -0.95 in 2025.
  • Its Interest Coverage Ratio was -0.95 in Q3 2025, compared to -3.42 in Q2 2025 and -4.36 in Q1 2025.